Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2025-12-25 @ 10:24 PM
NCT ID:
NCT02193958
Group ID:
EG006
Title:
Phase 1 Cohort 7: 400mg/m2
Description:
FF-10501-01 tablets BID every 21 days of a 28 day cycle.
FF-10501-01: FF-10501-01 will be administered orally on Days 1-21 of a 28-say cycle (Cohort 7). The dose-escalation will proceed until Maximum Tolerated Dose (MTD) is reached. The treatment will continue until disease progression, intolerable toxicity or investigation/subject decision.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
5
Other Number Affected:
5
Other Number At Risk:
5
Study:
NCT02193958
Results Section:
NCT02193958
Adverse Events Module:
NCT02193958